DGNS: PT Diagnos Laboratorium Utama Tbk - Summary | Jitta

PT Diagnos Laboratorium Utama Tbk

IDN:DGNS

Price
Rp232.00
Loss Chance
50.9%
3.91JITTA SCORE
181.50%Over Jitta Line
Jitta Ranking
306 / 854
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (59)
Recent Business Performance (54)
Financial Strength (62)
Return to Shareholders (9)
Competitive Advantage (37)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2023
Operating MarginInconsistent
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.91
181.50%
4.28
542.88%
Health Care Services
4.90
4.50%
COMPANY DESCRIPTION
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia, and other bacteria; genomics; homecare services; and inspection panel tests. It also provides clinical pathology, anatomical pathology, and microbiology laboratory; and corporate health and research services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.